The Pharma Letter4 天
Pfizer lures former J&J exec to be its CIMO
US pharma giant Pfizer (NYSE: PFE) today announced that James List, has joined the company as chief internal medicine officer ...
Pfizer appoints former J&J executive to lead obesity drug development
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Pfizer boosts anti-obesity efforts: adds former J&J exec. as chief internal medicine officer
Pfizer (PFE) stock gains as company appoints James List, a former J&J (JNJ) executive as Chief Internal Medicine Officer to ...
辉瑞高层大调整，2项重要人事任命
近日，全球制药巨头辉瑞（Pfizer）接连宣布两项重要人事任命，进一步强化其在药物研发与临床开发领域的领导力。前美国FDA药品评价与研究中心（CDER）主任Patrizia Cavazzoni博士回归辉瑞，担任首席医学官（Chief Medical ...
辉瑞高层大调整
近日，全球制药巨头辉瑞（Pfizer）接连宣布两项重要人事任命，进一步强化其在药物研发与临床开发领域的领导力。前美国FDA药品评价与研究中心（CDER）主任Patrizia Cavazzoni博士回归辉瑞，担任首席医学官（Chief Medical ...
BioPharma Dive6 天
Roche launches new Boston center; NIH centralizes peer review
The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy ...
Pfizer Appoints Ex-J&J Leader to Accelerate Weight Loss Solutions
Pfizer Supercharges Obesity Battle with Top J&J Exec ...
Reuters3 天
Pfizer Inc
Pfizer appoints former J&J executive to lead obesity drug development Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Yahoo Finance2 天
Pfizer Inc. (PFE)
After hours: March 12 at 7:59:30 PM EDT Loading Chart for PFE ...